CSF3 and neutropenia: Although higher rates of grade 3/4 neutropenia were observed with D-Rd in the frail subgroup compared to the total non-frail subgroup, these AEs were clinically manageable, and prompt granulocyte colony-stimulating factor (G-CSF) support should be provided for patients with neutropenia [55].